New COO takes over

Qureight’s new COO, Rebecca Simmons, brings extensive experience as an operational leader in medical research and deep tech. She previously served as COO at quantum computing company Riverlane. During this time, the company grew significantly in terms of both headcount and revenue. Simmons played a key role in closing funding rounds and raising more than £100m in venture capital. She also supported business development, including securing over £20m in government grants and contracts. Before joining Riverlane, Simmons was deputy director and co-founder of the THIS Institute (The Healthcare Improvement Studies Institute), where she built strategic partnerships with key players in the UK’s National Health Service (NHS). She also held senior advisory roles at the Danish Diabetes and Endocrine Academy.

At Qureight, she will strengthen the company’s global business activities and be responsible for sustainable growth initiatives. The company is currently driving the introduction and integration of its AI-powered CT imaging biomarkers and clinical data management platform in clinical trials for lung and heart disease.